Annual Non Current Assets
$10.38 M
+$2.84 M+37.57%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual long term assets is currently $10.38 million, with the most recent change of +$2.84 million (+37.57%) on 31 December 2023. During the last 3 years, it has fallen by -$18.21 million (-63.69%). EYPT annual non current assets is now -93.60% below its all-time high of $162.17 million, reached on 30 June 2006.EYPT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$32.37 M
+$3.05 M+10.40%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly long term assets is currently $32.37 million, with the most recent change of +$3.05 million (+10.40%) on 30 September 2024. Over the past year, it has increased by +$22.49 million (+227.61%). EYPT quarterly non current assets is now -80.04% below its all-time high of $162.17 million, reached on 30 June 2006.EYPT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.6% | +227.6% |
| 3 y3 years | -63.7% | +22.3% |
| 5 y5 years | -66.0% | +1.1% |
EYPT Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.7% | +37.6% | at high | +328.8% |
| 5 y | 5 years | -66.8% | +37.6% | at high | +328.8% |
| alltime | all time | -93.6% | +1008.2% | -80.0% | +5763.8% |
EyePoint Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.37 M(+10.4%) |
| June 2024 | - | $29.32 M(+154.1%) |
| Mar 2024 | - | $11.54 M(+11.1%) |
| Dec 2023 | $344.80 M(+99.5%) | $10.38 M(+5.1%) |
| Sept 2023 | - | $9.88 M(+15.7%) |
| June 2023 | - | $8.54 M(+0.0%) |
| Mar 2023 | - | $8.54 M(+13.1%) |
| Dec 2022 | $172.81 M(-27.3%) | $7.55 M(-73.4%) |
| Sept 2022 | - | $28.39 M(+3.0%) |
| June 2022 | - | $27.57 M(+10.6%) |
| Mar 2022 | - | $24.93 M(-2.7%) |
| Dec 2021 | $237.75 M(+276.7%) | $25.63 M(-3.2%) |
| Sept 2021 | - | $26.48 M(-1.9%) |
| June 2021 | - | $27.00 M(-2.8%) |
| Mar 2021 | - | $27.79 M(-2.8%) |
| Dec 2020 | $63.12 M(+51.3%) | $28.60 M(-2.1%) |
| Sept 2020 | - | $29.20 M(-2.2%) |
| June 2020 | - | $29.85 M(-2.4%) |
| Mar 2020 | - | $30.60 M(-2.1%) |
| Dec 2019 | $41.72 M(-12.4%) | $31.25 M(-2.3%) |
| Sept 2019 | - | $32.01 M(-2.3%) |
| June 2019 | - | $32.76 M(-2.2%) |
| Mar 2019 | - | $33.48 M(+7.3%) |
| Dec 2018 | $47.60 M(+19.3%) | - |
| Sept 2018 | - | $31.21 M(-1.7%) |
| June 2018 | $39.91 M(+125.0%) | $31.76 M(-2.2%) |
| Mar 2018 | - | $32.48 M(+5784.6%) |
| Dec 2017 | - | $552.00 K(-29.2%) |
| Sept 2017 | - | $780.00 K(-16.8%) |
| June 2017 | $17.74 M(-40.8%) | $937.00 K(-9.5%) |
| Mar 2017 | - | $1.03 M(-14.5%) |
| Dec 2016 | - | $1.21 M(-15.3%) |
| Sept 2016 | - | $1.43 M(-13.6%) |
| June 2016 | $29.96 M(+0.4%) | $1.66 M(-12.2%) |
| Mar 2016 | - | $1.89 M(-9.6%) |
| Dec 2015 | - | $2.09 M(-9.1%) |
| Sept 2015 | - | $2.30 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $29.84 M(+54.3%) | $2.53 M(-3.7%) |
| Mar 2015 | - | $2.63 M(-7.3%) |
| Dec 2014 | - | $2.83 M(-7.3%) |
| Sept 2014 | - | $3.06 M(-8.2%) |
| June 2014 | $19.34 M(+55.2%) | $3.33 M(-6.5%) |
| Mar 2014 | - | $3.56 M(-0.8%) |
| Dec 2013 | - | $3.59 M(-1.0%) |
| Sept 2013 | - | $3.62 M(-4.3%) |
| June 2013 | $12.46 M(-21.9%) | $3.79 M(-3.3%) |
| Mar 2013 | - | $3.92 M(-7.5%) |
| Dec 2012 | - | $4.23 M(-4.7%) |
| Sept 2012 | - | $4.44 M(-4.3%) |
| June 2012 | $15.96 M(-37.1%) | $4.64 M(-6.1%) |
| Mar 2012 | - | $4.94 M(-3.1%) |
| Dec 2011 | - | $5.09 M(-75.6%) |
| Sept 2011 | - | $20.86 M(-4.1%) |
| June 2011 | $25.37 M(+33.3%) | $21.75 M(-3.8%) |
| Mar 2011 | - | $22.60 M(-5.6%) |
| Sept 2010 | - | $23.95 M(-0.1%) |
| June 2010 | $19.03 M(+134.2%) | $23.98 M(-3.3%) |
| Mar 2010 | - | $24.79 M(-6.7%) |
| Dec 2009 | - | $26.57 M(-3.0%) |
| Sept 2009 | - | $27.40 M(-5.5%) |
| June 2009 | $8.13 M(-54.1%) | $28.98 M(+7.3%) |
| Mar 2009 | - | $27.00 M(-4.7%) |
| Dec 2008 | - | $28.32 M(-16.6%) |
| Sept 2008 | - | $33.98 M(-10.8%) |
| June 2008 | $17.69 M(+210.7%) | $38.09 M(-59.2%) |
| Mar 2008 | - | $93.46 M(-1.1%) |
| Dec 2007 | - | $94.53 M(-2.5%) |
| Sept 2007 | - | $96.97 M(+0.2%) |
| June 2007 | $5.69 M(-55.1%) | $96.81 M(+5.9%) |
| Dec 2006 | - | $91.44 M(-43.6%) |
| June 2006 | $12.68 M(+19.9%) | $162.17 M(+174.0%) |
| June 2005 | $10.57 M(-52.0%) | $59.19 M(+886.2%) |
| June 2004 | $22.05 M(+2406.4%) | $6.00 M(+52.3%) |
| June 2003 | $879.70 K(-49.2%) | $3.94 M |
| June 2001 | $1.73 M | - |
FAQ
- What is EyePoint Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual non current assets year-on-year change?
- What is EyePoint Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly non current assets year-on-year change?
What is EyePoint Pharmaceuticals annual long term assets?
The current annual non current assets of EYPT is $10.38 M
What is the all time high annual non current assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual long term assets is $162.17 M
What is EyePoint Pharmaceuticals annual non current assets year-on-year change?
Over the past year, EYPT annual long term assets has changed by +$2.84 M (+37.57%)
What is EyePoint Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of EYPT is $32.37 M
What is the all time high quarterly non current assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly long term assets is $162.17 M
What is EyePoint Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, EYPT quarterly long term assets has changed by +$22.49 M (+227.61%)